Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Oct 1 - Oct 6
(2013) Safety and Tolerability of the Hexadecapeptide AOD9604 in Humans J Endocrinol Metab 3(12):715 AOD9604 vs Related GH-Axis Research Tools AOD9604s unique combination of GH receptor independence, direct lipolytic activity, absence of IGF-1 stimulation, and confirmed oral bioavailability makes it an irreplaceable research tool for studying adipose tissue metabolism and lipolysis without the systemic endocrine confounds associated with intact hGH or indirect GH secretagogues
Comment: A commenter requested that CMS remove CPT Code 0877T from the current OPPS rule and fee schedule because according to the commenter, this service is best categorized as an ambulatory service, not an outpatient service to be reviewed and priced under the OPPS
This might seem counterintuitive if you've heard otherwise, but it highlights the complexity of nutritional science
Government negotiated price: The price the government pays to drugmakers (Eli Lilly and Novo Nordisk) will be reduced to $245 per month for injectables, which is less than half the previous list prices
US$ 29.15
US$ 27.82
US$ 23.35
US$ 26.78
US$ 22.06
US$ 28.80
US$ 21.29
